Le Lézard
Classified in: Health
Subjects: MAV, FVT

Media Invitation - Significant support to the McGill University Health Centre's (MUHC) Mental Health Mission


MONTRÉAL, Jan. 19, 2018 /CNW Telbec/ - The Montreal General Hospital Foundation invites representatives of the media to attend an important announcement regarding leading-edge mental health care at the Montreal General Hospital, on Monday, January 22, 2018 at 10 a.m., at 1650 Cedar Avenue.

 

Who:

Martine Alfonso, Interim President and General Director, McGill University Health Centre

Jean-Guy Gourdeau, President and CEO, Montreal General Hospital Foundation

Dr. Michaela Barbarosie, Director, Neuromodulation Unit, McGill University Health Centre

When:

Monday, January 22, 2018

10 a.m.                



Where:

Montreal General Hospital

Livingston Hall (L6-500)

1650 Cedar Avenue

Montréal, Québec, H3G 1A4

 

SOURCE Montreal General Hospital Foundation


These press releases may also interest you

at 07:35
Cybin to Participate at the 27th Annual Milken Institute Global Conference
Cybin Inc. (Cboe CA:CYBN) ("Cybin" or the "Company"), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation psychedelic-based treatment options, today announced...

at 07:35
Accuray Showcases Advances in Radiation Therapy Solutions Designed to Improve the Cancer Treatment Experience at ESTRO 2024
Accuray Incorporated announced today that the company is showcasing advances in hardware and software designed to improve the cancer treatment experience, at ESTRO 2024. The latest generation CyberKnife® and Radixact® platforms provide medical care...

at 07:30
Jushi Holdings Inc. to Report First Quarter 2024 Financial Results on May 9, 2024
Jushi Holdings Inc. ("Jushi" or the "Company") , a vertically integrated, multi-state cannabis operator, announced that it expects to report its financial results for the first quarter ended March 31, 2024, after the market closes on Thursday, May...

at 07:30
Ziosoft to Feature New Ziostation REVORAS Platform at the Annual American Association of Thoracic Surgeons Conference
Ziosoft, a pioneer in 3D/4D AI medical visualization, will feature its unique REVORAS-enabled thoracic surgical planning capabilities at the annual American Association of Thoracic Surgeons (AATS) conference being held April 27 - 29, 2024 in Toronto,...

at 07:30
Soligenix Extends Patent Protection for its Filovirus Vaccine Platform to the United Kingdom and South Africa
Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that it has received notice of intent...

at 07:25
Owlstone Medical Secures $6.5 Million to Support Development of Breath-based Diagnostics for Infectious Disease
Owlstone Medical ("Owlstone"), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced it has secured funding from the Bill & Melinda Gates Foundation ("the Gates Foundation" or "the...

More news about Health...


News published on and distributed by: